News

Transcranial Neurostimulation Reduced Postop Pain, Opioid Use

Publish date: May 10, 2012

 

FROM THE ANNUAL MEETING OF THE SOCIETY OF BEHAVIORAL MEDICINE

"We’re not really sure of the best way to do tDCS: the best targets, best intensities, best frequencies. But we’re getting there quickly," Dr. Borckardt said.

He reported having no financial conflicts.

Pages

Recommended Reading

Asymptomatic Neurocognitive Impairment Quantified in HIV-Positive Patients
MDedge Neurology
Ask Alzheimer's Patient Caregiver: Patch or Pill Therapy?
MDedge Neurology
Neuropsychological Impairment Detected Early in Course of HIV
MDedge Neurology
Amyloid Imaging Agent May Aid Alzheimer's Diagnosis
MDedge Neurology
Azotemia, Anemia Predict Medical Deterioration in Dementia Inpatients
MDedge Neurology
Obstacles Block the Way to Formulating a Creative Plan
MDedge Neurology
Knowledge of New Mutation in ALS, Dementia Grows
MDedge Neurology
Autopsy, Biopsy Data Support Amyloid Imaging Agents
MDedge Neurology
Amyloid-Beta-Associated Cognitive Decline Only Occurs at High P-Tau Levels
MDedge Neurology
New and Noteworthy Information—May
MDedge Neurology